Melatonin 5 mg
Melatonin 5 mg is a pharmaceutical drug with 13 clinical trials. Currently 4 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
1
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
4
trials recruiting
13
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Melatonin on Post Operative Pain After CS
Melatonin and Osteogenic Loading on Osteopenia
Melatonin Use After Primary Total Joint Arthroplasty
Improving Sleep Quality After Total Joint Arthroplasty ( TJA)
Exogenous Melatonin in Intensive Care Unit Chronodisruption
Clinical Trials (13)
Melatonin on Post Operative Pain After CS
Melatonin and Osteogenic Loading on Osteopenia
Melatonin Use After Primary Total Joint Arthroplasty
Improving Sleep Quality After Total Joint Arthroplasty ( TJA)
Exogenous Melatonin in Intensive Care Unit Chronodisruption
Melatonin on Anxiety and Sleep Quality in Adults Undergoing Coronary Artery Bypass Graft Surgery
TKA Melatonin and Sleep Quality
The Role of Preoperative Melatonin in Reducing the Inhaled Isoflurane Requirements in Open Nephrectomy
Clinical Trial of Antioxidant Therapy in Patients With Septic Shock
The Impact of Air Travel on Passenger Cognitive Functions
Efficacy of the Administration of Melatonin 5mg in the Prevention of Delirium in Older Adults Hospitalized in the Emergency Department
Melatonin as Adjuvant Treatment for ADHD in Adults
Effect of Melatonin on Sleep Quality in Patients Dementia
All 13 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 13